Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus

PURPOSE OF REVIEW: Sodium glucose cotransporter 2 (SGLT2) inhibitors are relatively novel antidiabetic drugs that improve glycemic control and reduce cardiovascular outcomes as well as renal function decline. SGLT2 inhibitors act by inhibiting glucose reabsorption in the proximal tubule of the kidne...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Curr Opin Nephrol Hypertens
Egile Nagusiak: Vinke, Joanna Sophia J., Heerspink, Hiddo J.L., de Borst, Martin H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2019
Gaiak:
MINERAL METABOLISM: Edited by Aline Martin and Tamara Isakova
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587226/
https://ncbi.nlm.nih.gov/pubmed/30958403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000505
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak